Small Molecule Drug Product CDMO Benchmarking (7th Ed.)

Report Overview

ISR’s Small Molecule Drug Product CDMO Benchmarking (7th Edition) report brings with it a wealth of knowledge and information, created with two goals in mind: to help biopharmaceutical companies make more informed CDMO decisions, and to help CDMOs optimize operational and marketing strategies.

This report provides biopharma companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CDMO service quality across a series of 24 performance attributes specific to outsourced drug product manufacturing. In this Consumer Reports-style analysis, ISR presents data on 528 service encounters from 140 respondents who have been involved in outsourced drug product projects in the past 18 months.

What you will learn:

Drug Developers:

• Make a more educated purchase of CDMO services by understanding which manufacturers best fit your company’s needs in addition to how individual CDMOs have measured up to sponsor-peer expectations on similar projects
• Uncover which CDMO attributes drive outsourcing partner selection for drug product manufacturing as well as which CDMO attributes have gained importance over the past 12 months among industry peers
• Gain insight into CDMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience 

Contract Manufacturers:

• Understand your company’s competitive positioning as well as delivery strengths and weaknesses and use this information to develop targeted messaging on true areas of strength
• Compare your company’s performance against its competitors across 24 performance metrics specific to outsourced drug product manufacturing and related services
• Gain insight into drug developers’ outsourcing preferences and practices with respect to CDMO selection and CDMO preference for outsourced small molecule drug product manufacturing

Major Topics:

• Outsourcing Philosophies and Practices
• CDMO Selection Drivers
• CDMO Performance and Loyalty
• The Small Molecule Drug Product CDMO Competitive Landscape
• Company Service Quality Profiles
• Study Data